SCHEMBL20350499

SCHEMBL20350499

Nc1nc(C(=O)Nc2cc(N3CCN(C(=O)O)C(CC4CNC4)C3)ccc2Cl)co1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PAICS P22234 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20350530 0.86 PAICS (0.54) PAICS
SCHEMBL20350501 0.80 PAICS (0.51) PAICS
SCHEMBL20352035 0.78 PAICS (0.67) PAICS
SCHEMBL28322401 0.78 PAICS (0.54) PAICS
SCHEMBL20350531 0.77 PAICS (0.51) PAICS
SCHEMBL24220398 0.76 PAICS (0.61) PAICS
SCHEMBL20339033 0.74 PAICS (0.58) PAICS
SCHEMBL21571670 0.74 PAICS (0.46) PAICS
SCHEMBL20339051 0.73 PAICS (0.55) PAICS
SCHEMBL20339065 0.73 PAICS (0.53) PAICS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562824-A1 OXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER LifeArc (GB) 2019-11-06 — — EP disclosed
WO-2018122549-A1 OXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER LIFEARC (GB) 2018-07-05 — — WO disclosed
Send feedback